Ankle Exoskeleton for Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a robotic ankle exoskeleton designed to improve walking ability in stroke survivors. Researchers seek to determine if the exoskeleton's new algorithms enhance walking compared to not using the device. It targets individuals who had a stroke at least six months ago, live independently, and can walk unaided. Participants will walk on treadmills and various surfaces to assess the device's effectiveness. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance mobility for stroke survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the research team or your doctor.
What prior data suggests that this ankle exoskeleton is safe for stroke patients?
Research has shown that stroke patients generally receive robotic exoskeletons for walking training well. Studies have found that these devices can improve walking speed, balance, and stamina. Strong evidence of serious side effects is lacking, making them a promising recovery option. Most patients have used the exoskeletons without major problems. While some might experience minor discomfort or need time to adjust, the treatment is considered safe based on current data. For those considering joining this type of trial, these findings suggest a positive safety outlook.12345
Why are researchers excited about this trial?
Researchers are excited about the ankle exoskeleton for stroke rehabilitation because it offers a unique, robotic approach to gait assistance. Unlike conventional treatments like physical therapy and ankle-foot orthoses, this exoskeleton provides powered support to the ankle, potentially enhancing mobility and reducing the effort needed for walking. By actively assisting the ankle joint, it could help stroke survivors improve their walking ability more efficiently. This innovative technology aims to complement existing therapies, offering a dynamic and adjustable solution tailored to the individual's needs.
What evidence suggests that this ankle exoskeleton is effective for stroke?
Research has shown that ankle exoskeletons can aid stroke recovery. One study found that a robotic exoskeleton increased walking speed in stroke patients. Another study demonstrated improved joint movement and muscle use with these devices. Wearable robots for walking training also resulted in faster walking and better endurance compared to regular therapy. Overall, these findings suggest that ankle exoskeletons may enhance walking abilities in stroke survivors. Participants in this trial will use the powered ankle exoskeleton to assess its effectiveness in gait assistance for stroke recovery.12346
Who Is on the Research Team?
Aaron Young, PhD
Principal Investigator
Georgia Institute of Technology
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-85 who had a stroke at least 6 months ago, can walk without someone's help (FAC score of 3+), live independently, and can consent to participate. It's not for those who don't fit the exoskeleton, shuffle when walking, need assistance or a walker to walk, or have other severe impairments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants perform movement tasks without the ankle exoskeleton to establish baseline conditions
Treatment
Participants are fitted with an ankle exoskeleton and perform movement tasks to test the new AI algorithms
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Ankle Exoskeleton
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgia Institute of Technology
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator